title: Predicting abuse potential of stimulants and other dopaminergic drugs: overview and recommendations.
abstract: Examination of a drug's abuse potential at multiple levels of analysis (molecular/cellular action, whole-organism behavior, epidemiological data) is an essential component to regulating controlled substances under the Controlled Substances Act (CSA). We reviewed studies that examined several central nervous system (CNS) stimulants, focusing on those with primarily dopaminergic actions, in drug self-administration, drug discrimination, and physical dependence. For drug self-administration and drug discrimination, we distinguished between experiments conducted with rats and nonhuman primates (NHP) to highlight the common and unique attributes of each model in the assessment of abuse potential. Our review of drug self-administration studies suggests that this procedure is important in predicting abuse potential of dopaminergic compounds, but there were many false positives. We recommended that tests to determine how reinforcing a drug is relative to a known drug of abuse may be more predictive of abuse potential than tests that yield a binary, yes-or-no classification. Several false positives also occurred with drug discrimination. With this procedure, we recommended that future research follow a standard decision-tree approach that may require examining the drug being tested for abuse potential as the training stimulus. This approach would also allow several known drugs of abuse to be tested for substitution, and this may reduce false positives. Finally, we reviewed evidence of physical dependence with stimulants and discussed the feasibility of modeling these phenomena in nonhuman animals in a rational and practical fashion. This article is part of the Special Issue entitled 'CNS Stimulants'.
authors.affiliation: Division of Neurobiology and Behavior Research, Department of Psychiatry and Human Behavior, The University of Mississippi Medical Center, 2500 N. State Street, Jackson, MS 39216, USA. Electronic address: shuskinson@umc.edu.
authors.forename: Sally L
authors.initials: SL
authors.lastname: Huskinson
authors.affiliation: Division of Neurobiology and Behavior Research, Department of Psychiatry and Human Behavior, The University of Mississippi Medical Center, 2500 N. State Street, Jackson, MS 39216, USA.
authors.forename: Jennifer E
authors.initials: JE
authors.lastname: Naylor
authors.affiliation: Division of Neurobiology and Behavior Research, Department of Psychiatry and Human Behavior, The University of Mississippi Medical Center, 2500 N. State Street, Jackson, MS 39216, USA.
authors.forename: James K
authors.initials: JK
authors.lastname: Rowlett
authors.affiliation: Division of Neurobiology and Behavior Research, Department of Psychiatry and Human Behavior, The University of Mississippi Medical Center, 2500 N. State Street, Jackson, MS 39216, USA.
authors.forename: Kevin B
authors.initials: KB
authors.lastname: Freeman
mesh_terms: D000818:Animals; D000697:Central Nervous System Stimulants / Q000008:administration & dosage*; D004195:Disease Models, Animal; D015259:Dopamine Agents / Q000008:administration & dosage*; D004353:Drug Evaluation, Preclinical / Q000379:methods*; D006801:Humans; D012646:Self Administration; D019966:Substance-Related Disorders / Q000175:diagnosis / Q000503:physiopathology / Q000517:prevention & control
chemical_list: D000697:Central Nervous System Stimulants; D015259:Dopamine Agents
keywords: Abuse potential; Animal model; Drug discrimination; Physical dependence; Self-administration; Stimulant